|
|
|
Esperoct® is used to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A.
See full indication below. |
|
|
|
|
| “Growing up, my condition continued to progress. It was hard. I was always in pain. I started on Esperoct® in 2020…I wanted a product that could travel with me everywhere I go. One of the things I really love about Esperoct® is the flexibility it gives you. Managing my care with my doctor and identifying a treatment that works for me has made a difference in reducing the frequency of my bleeding episodes.” |
| Individual results may vary. |
|
|
|
|
| Selected Important Safety Information |
| Who should not use Esperoct®? |
| |
• |
You should not use Esperoct® if you are allergic to factor VIII or any of the other ingredients of Esperoct® or if you are allergic to hamster proteins |
|
| What is the most important information I need to know about Esperoct®? |
| |
• |
Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center |
|
| |
• |
Call your healthcare provider right away or get emergency treatment right away if you get any signs of an allergic reaction, such as: hives, chest tightness, wheezing, dizziness, difficulty breathing, and/or swelling of the face |
|
| Please click here or scroll below for additional Important Safety Information. |
|
|
|
| To find the right treatment for his severe hemophilia A, Bradley worked with his doctors and support system, did his own research, and asked a lot of questions. His local Hemophilia Community Liaison (HCL) provided all the information he wanted about Esperoct®. |
| Since he made the switch, his HCL has continued to be a great resource for connecting Bradley to local events, providing lifestyle tips, and more. |
|
|
|
|
|
| Your Esperoct® story matters and we want to highlight it in a big way! Sharing your experiences with hemophilia A and successfully treating with Esperoct® could inspire others in the bleeding disorders community. |
|
|
|
|
| What is Esperoct®? |
| Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] is an injectable medicine to treat and prevent or reduce the number of bleeding episodes in people with hemophilia A. Your healthcare provider may give you Esperoct® when you have surgery |
| |
• |
Esperoct® is not used to treat von Willebrand Disease |
|
| Important Safety Information (cont’d) |
| What should I tell my healthcare provider before using Esperoct®? |
| |
• |
Before taking Esperoct®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII |
| |
• |
Your body can make antibodies called “inhibitors” against Esperoct®, which may stop Esperoct® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Esperoct® |
|
| What are the possible side effects of Esperoct®? |
| |
• |
Common side effects of Esperoct® include rash or itching, and swelling, pain, rash or redness at the location of infusion |
|
| Please click here for Prescribing Information. |
| Esperoct® is a prescription medication. |
| You are encouraged to report negative side effects of prescription drugs to the FDA. |
| Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. |
|
|
| Please do not respond to this email. If you would like to contact us, please click here or call 1-877-744-2579. |
|
Esperoct® is a registered trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2022 Novo Nordisk All rights reserved. US22ESP00025 August 2022 |
 |
|
|
|
